In a similar study, the same group showed results in paediatric IBD where glucocorticoid therapy reduced serum MMP-7, TIMP-1, and MMP-7/TIMP-2 and anti-TNF therapy reduced MMP-7 but to a lesser extent. The gene discussed is TNF; the disease is inflammatory bowel disease.